- Drug harms in the UK: a multicriteria decision analysis
[作者：Nutt, DJ; King, LA; Phillips, LD,期刊：Lancet, 页码：1558-1565 , 文章类型： Article，,卷期：2010年376-9752]
- Background Proper assessment of the harms caused by the misuse of drugs can inform policy makers in health, policing, and social care. We aimed to apply multicriteria decision analysis (MCDA) modelling to a range of drug...
- Malaria Elimination 1 Shrinking the malaria map: progress and prospects
[作者：Feachem, RGA; Phillips, AA; Hwang, J; Cotter, C; Wielgosz, B; Greenwood, BM; Sabot, O; Rodriguez, MH; Abeyasinghe, RR; Ghebreyesus, TA; Snow, RW,期刊：Lancet, 页码：1566-1578 , 文章类型： Article，,卷期：2010年376-9752]
- In the past 150 years, roughly half of the countries in the world eliminated malaria. Nowadays, there are 99 endemic countries-67 are controlling malaria and 32 are pursuing an elimination strategy. This four-part Series...
- Malaria Elimination 2 Ranking of elimination feasibility between malaria-endemic countries
[作者：Tatem, AJ; Smith, DL; Gething, PW; Kabaria, CW; Snow, RW; Hay, SI,期刊：Lancet, 页码：1579-1591 , 文章类型： Article，,卷期：2010年376-9752]
- Experience gained from the Global Malaria Eradication Program (1955-72) identified a set of shared technical and operational factors that enabled some countries to successfully eliminate malaria. Spatial data for these f...
- Malaria Elimination 3 Operational strategies to achieve and maintain malaria elimination
[作者：Moonen, B; Cohen, JM; Snow, RW; Slutsker, L; Drakeley, C; Smith, DL; Abeyasinghe, RR; Rodriguez, MH; Maharaj, R; Tanner, M; Targett, G,期刊：Lancet, 页码：1592-1603 , 文章类型： Article，,卷期：2010年376-9752]
- Present elimination strategies are based on recommendations derived during the Global Malaria Eradication Program of the 1960s. However, many countries considering elimination nowadays have high intrinsic transmission po...
- Malaria Elimination 4 Costs and financial feasibility of malaria elimination
[作者：Sabot, O; Cohen, JM; Hsiang, MS; Kahn, JG; Basu, S; Tang, LH; Zheng, B; Gao, Q; Zou, LD; Tatarsky, A; Aboobakar, S; Usas, J; Barrett, S; Cohen, JL; Jamison, DT; Feachem, RGA,期刊：Lancet, 页码：1604-1615 , 文章类型： Article，,卷期：2010年376-9752]
- The marginal costs and benefits of converting malaria programmes from a control to an elimination goal are central to strategic decisions, but empirical evidence is scarce. We present a conceptual framework to assess the...
- Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial (vol 373, pg 633, 2009)
[作者：Gottlieb, A; Menter, A; Mendelsohn, A,期刊：Lancet, 页码：1542-1542 , 文章类型： Correction，,卷期：2010年376-9752]
|